Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd‐DTPA‐enhanced MR imaging

Increased knowledge of the physiological basis behind the signal enhancement in tumors during dynamic contrast‐enhanced magnetic resonance (MR) imaging may be useful in development of predictive assays based on this technique. In the present work, the relative signal intensity (RSI) increase in gadopentetate dimeglumine (Gd‐DTPA)‐enhanced MR images of patients with cervical carcinoma was related to tumor perfusion, vascular density, cell density, and oxygen tension (pO2). The patients were subjected to MR imaging before the start of treatment (N = 12) and after two weeks of radiotherapy (N = 8). Perfusion was determined from the kinetics of contrast agent in tumors and arteries, vascular density and cell density were determined from tumor biopsies, and pO2 was determined by polarographic needle electrodes. The maximal RSI was correlated to perfusion (P = 0.002) and cell density (P = 0.004), but was not related to vascular density. There was also a correlation between pO2 and perfusion (P < 0.001). Moreover, pO2 tended to be correlated to cell density (P = 0.1), but was not related to vascular density. There was a significant correlation between RSI and pO2, regardless of whether the median pO2 (P < 0.001) or the fraction of pO2 readings below 2.5 mmHg (P < 0.001), 5 mmHg (P < 0.0001), or 10 mmHg (P < 0.001) was considered. Our results suggest that the Gd‐DTPA‐induced signal enhancement in MR images of cervical tumors is influenced by both perfusion and cell density. These parameters are also of major importance for tumor oxygenation, leading to a correlation between signal enhancement and oxygenation. Dynamic contrast‐enhanced MR imaging may therefore possibly be useful in prediction of treatment outcome. J. Magn. Reson. Imaging 2001;14:750–756. © 2001 Wiley‐Liss, Inc.

[1]  G Brix,et al.  Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. , 1998, Cancer research.

[2]  E. Löhr,et al.  Evaluation of tumor blood perfusion by dynamic MRI and CT in patients undergoing thermoradiotherapy. , 1993, European journal of radiology.

[3]  J L Evelhoch,et al.  Key factors in the acquisition of contrast kinetic data for oncology , 1999, Journal of magnetic resonance imaging : JMRI.

[4]  W T Yuh,et al.  MR microcirculation assessment in cervical cancer: Correlations with histomorphological tumor markers and clinical outcome , 1999, Journal of magnetic resonance imaging : JMRI.

[5]  H. Lyng,et al.  Measurement of perfusion rate in human melanoma xenografts by contrast‐enhanced magnetic resonance imaging , 1998, Magnetic resonance in medicine.

[6]  T. Roberts,et al.  Physiologic measurements by contrast‐enhanced MR imaging: Expectations and limitations , 1997, Journal of magnetic resonance imaging : JMRI.

[7]  H. Lyng,et al.  Prediction of treatment temperatures in clinical hyperthermia of locally advanced breast carcinoma: the use of contrast enhanced computed tomography. , 1993, International journal of radiation oncology, biology, physics.

[8]  M. Dewhirst,et al.  Tumor oxygenation: a matter of supply and demand. , 1996, Anticancer research.

[9]  W E Reddick,et al.  MR imaging of tumor microcirculation: Promise for the new millenium , 1999, Journal of magnetic resonance imaging : JMRI.

[10]  H. Lyng,et al.  Intra‐ and intertumor heterogeneity in blood perfusion of human cervical cancer before treatment and after radiotherapy , 2001, International journal of cancer.

[11]  M Recht,et al.  Method for the quantitative assessment of contrast agent uptake in dynamic contrast‐enhanced MRI , 1994, Magnetic resonance in medicine.

[12]  P Vaupel,et al.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.

[13]  R. Brasch,et al.  Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. , 1984, AJR. American journal of roentgenology.

[14]  H. Lyng,et al.  Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  W Zhen,et al.  Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer , 2000, Journal of magnetic resonance imaging : JMRI.

[16]  A. Fyles,et al.  Oxygenation predicts radiation response and survival in patients with cervix cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  J P Logue,et al.  Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  H Lyng,et al.  Changes in tumor oxygen tension during radiotherapy of uterine cervical cancer: relationships to changes in vascular density, cell density, and frequency of mitosis and apoptosis. , 2000, International journal of radiation oncology, biology, physics.

[19]  R. Pötter,et al.  Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  P. Pattynama,et al.  Cervical carcinoma: can dynamic contrast-enhanced MR imaging help predict tumor aggressiveness? , 1999, Radiology.

[21]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[22]  R. Jain,et al.  Delivery of molecular and cellular medicine to solid tumors. , 1998, Journal of controlled release : official journal of the Controlled Release Society.